It now appears that funding for the National Institute of Biomedical
Imaging and Bioengineering will remain approximately level in FY 2007.
The Senate Appropriations Committee has sent S. 3708, the Departments
of Labor, Health and Human Services, and Education, and Related Agencies
Appropriations Bill to the floor. This bill provides funding for the
National Institutes of Health, of which NIBIB is a part. Overall NIH
FY 2007 funding in the Senate bill is $28.5 billion, which a committee
statement notes is "an increase of $220 million over the FY 06
appropriation and $200 million over the President's budget request."
Here are the numbers:
Current NIBIB funding is $296.6 million.
The Administration requested $294.9 million, a reduction of 0.6% or
The House Appropriations Committee's bill provides the Administration
The Senate bill recommends $297.6 million, an increase of 0.3% or $1.0
Accompanying this bill is Senate Report 109-287, which can be accessed
The Senate Report language is below. See http://www.aip.org/fyi/2006/082.html
for the comparable House language.
"The Committee recommends an appropriation of $297,606,000
for the National Institute of Biomedical Imaging and Bioengineering
[NIBIB]. The budget requested $294,850,000 and the fiscal year 2006
appropriation was $296,606,000. The comparable amounts for the budget
estimate include funds to be transferred from the Office of AIDS Research.
"Artificial Pancreas.--Maintaining blood glucose levels
as close to normal values as possible is proven to reduce the risk
of long-term complications in diabetes. However, tight glucose control
is difficult to achieve, especially in young children. The NIBIB is
encouraged to expedite research on closing the loop' between
glucose monitoring technologies and insulin delivery devices as a
means to automate glucose control and improve disease management.
"Image-guided Surgery- The Committee continues to be
encouraged by the potential of image-guided surgery to improve patient
outcomes. The Committee supports the Institute's efforts to expand
its efforts in this area.
"Liver Imaging Techniques- Consistent with NIBIB's mission
to improve all diagnostic imaging technologies, the Committee urges
NIBIB to continue to make liver imaging techniques a primary focus,
speeding the development of new modalities that better capture the
early stages of various liver diseases, including cancer, as well
as offering the potential for less invasive combinations of diagnosis
and treatment and the evaluation of livers from cadaver donors. The
Committee urges NIBIB to participate actively in trans-NIH initiatives
that address these priorities.
"Liver Tissue Engineering- The Committee urges NIBIB
to focus efforts on expanding the Tissue Engineering Program to examine
how the development and function of engineered tissues and organs
can improve treatment techniques for patients afflicted with liver
"PET and MicroPET- The Committee continues to encourage
the Institute to provide increased support for molecular imaging technologies
such as positron emission tomography [PET] and microPET to take advantage
of the capacities of molecular imaging to detect disease process at
the molecular level and to monitor the effectiveness of targeted gene
therapies now under development. The Committee also encourages the
Institute to develop its research agenda in close collaboration with
other, disease-specific Institutes at NIH, so that new imaging technologies
are closely tied to the research projects being undertaken by the
various other Institutes of NIH."